Mechanism and management of migraine.
Migraine is a condition that affects 10%-15% of the population. Abortive treatment is always indicated because the intense headaches interfere with normal functioning. Preventive treatment is indicated when the headaches exceed 3-4 per month.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008881:Migraine Disorders / Q000503:physiopathology* / Q000628:therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013699:Temporal Arteries / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents